↓ Skip to main content

Cochrane Database of Systematic Reviews

Benzodiazepines for restless legs syndrome

Overview of attention for article published in Cochrane database of systematic reviews, March 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
16 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
99 Mendeley
Title
Benzodiazepines for restless legs syndrome
Published in
Cochrane database of systematic reviews, March 2017
DOI 10.1002/14651858.cd006939.pub2
Pubmed ID
Authors

Karla Carlos, Gilmar F Prado, Camila DM Teixeira, Cristiane Conti, Marcio M de Oliveira, Lucila BF Prado, Luciane BC Carvalho

Abstract

Restless legs syndrome (RLS) is a common disease affecting about 5% to 15% of the population. Symptoms of RLS can be severe in a minority of and can have a major impact on sleep, mostly sleep initiation, and quality of life. Benzodiazepines are drugs that can induce and maintain sleep and, hence, intuitively are thought to be beneficial to people with RLS. Altough benzodiazepines, particularly clonazepam, are used to treat RLS symptoms, a systematic review done by the American Academy of Sleep Medicine stated that benzodiazepines should not be used as a first-line treatment, although could be used as a coadjuvant therapy. To evaluate the efficacy and safety of benzodiazepine compared to placebo or other treatment for idiopathic RLS, including unconfounded trials comparing benzodiazepines versus open control. In March 2016 we searched CENTRAL, MEDLINE, Embase and LILACS We checked the references of each study and contacted study authors to identify any additional studies. We considered studies published in any language. Randomised clinical trials of benzodiazepine treatment in idiopathic RLS. We did not perform data collection and analysis, since we did not include any studies, MAIN RESULTS: We did not identify any studies that met the inclusion criteria of the review. Two cross-over studies are awaiting classification because the cross-over trials did not give data at the end of the first cross-over period. The effectiveness of benzodiazepines for RLS treatment is currently unknown.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 99 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 18%
Student > Bachelor 15 15%
Researcher 14 14%
Other 8 8%
Student > Postgraduate 4 4%
Other 18 18%
Unknown 22 22%
Readers by discipline Count As %
Medicine and Dentistry 38 38%
Nursing and Health Professions 11 11%
Psychology 4 4%
Agricultural and Biological Sciences 3 3%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 13 13%
Unknown 27 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#2,172,330
of 21,554,340 outputs
Outputs from Cochrane database of systematic reviews
#4,728
of 12,071 outputs
Outputs of similar age
#43,264
of 284,175 outputs
Outputs of similar age from Cochrane database of systematic reviews
#119
of 256 outputs
Altmetric has tracked 21,554,340 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,071 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,175 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 256 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.